fovinaciclib   Click here for help

GtoPdb Ligand ID: 13207

Synonyms: Example 5 [WO2017193872]
Compound class: Synthetic organic
Comment: The chemical structure for fovinaciclib was obtained from proposed INN list 130 (Feb. 2024), in which the compound is described as cyclin dependent kinase (CDK) inhibitor with antineoplastic potential. This compound is claimed in patent WO2017193872A1 [1].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 9
Hydrogen bond donors 1
Rotatable bonds 7
Topological polar surface area 104.44
Molecular weight 548.75
XLogP 1.92
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CN(C)C(=O)C1=C(C2CCCC2)C3=NC(=NC=C3S1)NC4=CC=C(C=N4)N5CCC(CC5)N6CCN(C)CC6
Isomeric SMILES C1(CCCC1)C2=C(SC3=C2N=C(N=C3)NC4=NC=C(C=C4)N5CCC(CC5)N6CCN(CC6)C)C(=O)N(C)C
InChI InChI=1S/C29H40N8OS/c1-34(2)28(38)27-25(20-6-4-5-7-20)26-23(39-27)19-31-29(33-26)32-24-9-8-22(18-30-24)36-12-10-21(11-13-36)37-16-14-35(3)15-17-37/h8-9,18-21H,4-7,10-17H2,1-3H3,(H,30,31,32,33)
InChI Key PGGPKYATZSPYKB-UHFFFAOYSA-N
References
1. Zhao X, Li T, Chen Z, Tan R, Chen L, Wang X, Yang L, Zhou Z, Liu Y, Lin M et al.. (2017)
Certain protein kinase inhibitors.
Patent number: WO2017193872A1. Assignee: Shanghai Fochon Pharmaceutical Co., Ltd., Chongqing Fochon Pharmaceutical Co., Ltd.. Priority date: 05/05/2017. Publication date: 16/11/2017.